These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 27026343)

  • 1. VIP protects human retinal microvascular endothelial cells against high glucose-induced increases in TNF-α and enhances RvD1.
    Shi H; Carion TW; Jiang Y; Steinle JJ; Berger EA
    Prostaglandins Other Lipid Mediat; 2016 Mar; 123():28-32. PubMed ID: 27026343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasoactive intestinal peptide increases VEGF expression to promote proliferation of brain vascular endothelial cells via the cAMP/PKA pathway after ischemic insult in vitro.
    Yang J; Shi QD; Song TB; Feng GF; Zang WJ; Zong CH; Chang L
    Peptides; 2013 Apr; 42():105-11. PubMed ID: 23340020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VIP attenuation of the severity of experimental pancreatitis is due to VPAC1 receptor-mediated inhibition of cytokine production.
    Kojima M; Ito T; Oono T; Hisano T; Igarashi H; Arita Y; Kawabe K; Coy DH; Jensen RT; Nawata H
    Pancreas; 2005 Jan; 30(1):62-70. PubMed ID: 15632701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VPAC1 (vasoactive intestinal peptide (VIP) receptor type 1) G protein-coupled receptor mediation of VIP enhancement of murine experimental colitis.
    Yadav M; Huang MC; Goetzl EJ
    Cell Immunol; 2011; 267(2):124-32. PubMed ID: 21295288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in the relative abundance of the vasoactive intestinal peptide receptors (VPAC1 and VPAC2) and functions in uterine contractility during inflammation.
    Palus K; Całka J; Jana B
    Anim Reprod Sci; 2021 Feb; 225():106680. PubMed ID: 33388613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biosynthesis of proresolving lipid mediators by vascular cells and tissues.
    Chatterjee A; Komshian S; Sansbury BE; Wu B; Mottola G; Chen M; Spite M; Conte MS
    FASEB J; 2017 Aug; 31(8):3393-3402. PubMed ID: 28442547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resolvin D1 inhibits TGF-β1-induced epithelial mesenchymal transition of A549 lung cancer cells via lipoxin A4 receptor/formyl peptide receptor 2 and GPR32.
    Lee HJ; Park MK; Lee EJ; Lee CH
    Int J Biochem Cell Biol; 2013 Dec; 45(12):2801-7. PubMed ID: 24120851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early changes in pituitary adenylate cyclase-activating peptide, vasoactive intestinal peptide and related receptors expression in retina of streptozotocin-induced diabetic rats.
    Giunta S; Castorina A; Bucolo C; Magro G; Drago F; D'Agata V
    Peptides; 2012 Sep; 37(1):32-9. PubMed ID: 22721946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered expression of vasoactive intestinal peptide receptors in T lymphocytes and aberrant Th1 immunity in multiple sclerosis.
    Sun W; Hong J; Zang YC; Liu X; Zhang JZ
    Int Immunol; 2006 Dec; 18(12):1691-700. PubMed ID: 17077178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human plasmacytoid dendritic cell function: inhibition of IFN-alpha secretion and modulation of immune phenotype by vasoactive intestinal peptide.
    Fabricius D; O'Dorisio MS; Blackwell S; Jahrsdörfer B
    J Immunol; 2006 Nov; 177(9):5920-7. PubMed ID: 17056516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RvD1 inhibits TNFα-induced c-Myc expression in normal intestinal epithelial cells and destabilizes hyper-expressed c-Myc in colon cancer cells.
    Zhong X; Lee HN; Surh YJ
    Biochem Biophys Res Commun; 2018 Feb; 496(2):316-323. PubMed ID: 29305860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VPAC1 receptors regulate intestinal secretion and muscle contractility by activating cholinergic neurons in guinea pig jejunum.
    Fung C; Unterweger P; Parry LJ; Bornstein JC; Foong JP
    Am J Physiol Gastrointest Liver Physiol; 2014 May; 306(9):G748-58. PubMed ID: 24578344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VIP and PACAP analogs regulate therapeutic targets in high-risk neuroblastoma cells.
    de Boisvilliers M; Perrin F; Hebache S; Balandre AC; Bensalma S; Garnier A; Vaudry D; Fournier A; Festy F; Muller JM; Chadéneau C
    Peptides; 2016 Apr; 78():30-41. PubMed ID: 26826611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VIP impairs acquisition of the macrophage proinflammatory polarization profile.
    Carrión M; Pérez-García S; Martínez C; Juarranz Y; Estrada-Capetillo L; Puig-Kröger A; Gomariz RP; Gutiérrez-Cañas I
    J Leukoc Biol; 2016 Dec; 100(6):1385-1393. PubMed ID: 27381006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A regulatory role for β-adrenergic receptors regarding the resolvin D1 (RvD1) pathway in the diabetic retina.
    Shi H; Carion TW; Jiang Y; Chahine A; Steinle JJ; Berger EA
    PLoS One; 2017; 12(11):e0185383. PubMed ID: 29095817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radical reversal of vasoactive intestinal peptide (VIP) receptors during early lymphopoiesis.
    Vomhof-DeKrey EE; Sandy AR; Failing JJ; Hermann RJ; Hoselton SA; Schuh JM; Weldon AJ; Payne KJ; Dorsam GP
    Peptides; 2011 Oct; 32(10):2058-66. PubMed ID: 21878358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A lymphocyte-generated fragment of vasoactive intestinal peptide with VPAC1 agonist activity and VPAC2 antagonist effects.
    Summers MA; O'Dorisio MS; Cox MO; Lara-Marquez M; Goetzl EJ
    J Pharmacol Exp Ther; 2003 Aug; 306(2):638-45. PubMed ID: 12750439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of vasoactive intestinal peptide to immune homeostasis in trophoblast-maternal leukocyte interaction under LPS stimulation.
    Fraccaroli L; Grasso E; Hauk V; Cortelezzi M; Pérez Leirós C; Ramhorst R
    Neuroimmunomodulation; 2014; 21(1):21-30. PubMed ID: 24135863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasoactive intestinal peptide maintains the nonpathogenic profile of human th17-polarized cells.
    Jimeno R; Leceta J; Martínez C; Gutiérrez-Cañas I; Carrión M; Pérez-García S; Garín M; Mellado M; Gomariz RP; Juarranz Y
    J Mol Neurosci; 2014 Nov; 54(3):512-25. PubMed ID: 24805298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloid ALX/FPR2 regulates vascularization following tissue injury.
    Sansbury BE; Li X; Wong B; Patsalos A; Giannakis N; Zhang MJ; Nagy L; Spite M
    Proc Natl Acad Sci U S A; 2020 Jun; 117(25):14354-14364. PubMed ID: 32513697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.